AnaptysBio, Inc. - Special Call
שיחת ועידה AnaptysBio Inc
AnaptysBio Inc Conference call or earnings call will be held on 24/09/2018 via an 800 number (toll-free). During the earnings conference call's session AnaptysBio Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact AnaptysBio Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation. We develop our product candidates to address emerging biological targets using our proprietary antibody discovery technology platform, which is based upon a breakthrough understanding of the natural process of antibody generation, known as somatic hypermutation, or SHM, and replicates this natural process of antibody generation in vitro. Our strategy is to advance the development of our proprietary product candidates, and for certain programs, establish partnerships with leading biopharmaceutical companies where we retain certain development and commercialization rights. Our most advanced wholly-owned antibody programs, ANB020 and ANB019, neutralize therapeutic targets that are genetically associated with severe inflammatory disorders in humans.קרא עוד שיחת ועידה